Introduction: With the development of
INTRODUCTION
With the development of magnetic resonance imaging (MRI), a lot of patients are addressed to neurologists to confirm diagnosis of multiple sclerosis (MS) when brain T2 abnormalities are found, whatever their characteristics, even if white matter abnormalities are non-specific.
Most of the time, the patient is presented with a radiological report notifying clearly the diagnosis of MS. A lot of non-specialized radiologists are not specifically aware of the clinico-radiological diagnosis leading to MS diagnosis. Diagnosis of MS is based on demonstrating dissemination in space (DS) and time on MRI and excluding other neurological disorders that can clinically and radiologically mimic MS [1] . The brain MRI motive has to be a seminal event, acute or progressive, suggestive of an inflammatory disease. When the patient suffers from suggestive MS symptoms, clinico-radiological criteria are helpful to diagnose a clinically isolated syndrome. McDonald criteria have been applied in clinical practice with good specificity for MRI criteria with two updates since the original publication but may require systematic screening (visual evoked potential, blood and cerebrospinal fluid analysis) [1] [2] [3] [4] [5] [6] .
Other criteria for diagnosis of MS have been recently proposed but are not yet validated [7] .
Eventually, a lot of patients diagnosed with potential MS are not diagnosed after a second screening [8, 9] .
For patients with non-typical MS symptoms, a systematic review of brain and spinal MRI is the major step to establish the diagnosis of a demyelinating disease. Recognition of MRI red flags, as defined by the European MAGNIMS (Magnetic Resonance Network in Multiple Sclerosis), improves diagnostic accuracy [10, 11] .
The limited specificity of incidental nonspecific white matter abnormalities that are revealed by MRI may increase the number of misdiagnosis [10] . Even prior to the introduction of radiologically isolated syndrome (RIS) criteria, longitudinal clinical data from individuals with incidentally identified T2 lesions suggestive of multiple sclerosis (MS) were described. Healthy individuals who do not exhibit signs of neurological dysfunction commonly have brain MRI studies performed for a reason other than an evaluation for MS that reveals unexpected anomalies highly suggestive of demyelinating plaques given their size, location, and morphology. These healthy subjects lack symptomatology suggestive of MS and fulfill formal criteria for RIS, a recently described MS subtype that expands upon the phenotype of at-risk individuals for future demyelinating events. A formal description of RIS was first introduced in 2009 by Okuda et al. [12] , to define this relevant cohort of individuals who are at risk for future demyelinating events.
The authors describe here a prospective study consisting of the evaluation in clinical practice of a step-by-step procedure in patients presenting with non-specific symptoms and brain T2 hyperintensities, initially diagnosed as RIS or MS.
METHODS
From 2009 to 2012, the authors ran standardized procedures on 220 consecutive patients referred to their MS center by general practitioners (GP) or neurologists for specialized advice concerning suspected MS on brain MRI.
Brain MRI was performed by the GP for nonspecific symptoms (such as headaches, atypical sensitive symptoms, blurred vision, and mood disorders).
Classification of the T2 Hyperintensities
Clinical and neurological data were reviewed with the patient and the brain MRI was analyzed by two physicians (neuroradiologists: LM, SC or 3 neurologists: CL, AC, MC) with a standardized procedure considering shape, size, number and location of T2 and T1 abnormalities on sequences with and without gadolinium ( Fig. 1 For the other recruited patients with nonspecific symptoms, a diagnosis was finally proposed on the combination of clinical, laboratory and radiological data.
Compliance with Ethics
All procedures followed were in accordance (Table 2) .
DS with MS/MRI criteria applied to the first brain MRI were fulfilled in 85% of MS, for 34.6% of the vascular patients, and for 0 of the nonspecific hyperT2 (Table 3 ). 38% of patients 
DISCUSSION
Brain MRI is the most sensitive paraclinical diagnostic test for MS, but white matter abnormalities are also known to be present in many other circumstances [1, [14] [15] [16] . They have been reported in 40-95% of patients with other neurological diseases [8] [9] [10] and even in 44% of elderly asymptomatic patients [13] .
Failure to consider the aspect of T2 hypersignals can induce misdiagnosis in some patients fulfilling the criteria of DT and DS. In these cases, proposing specific treatments that are available now can be risky.
Among our 220 suspected MS patients, 43%
were diagnosed with demyelinating disease and 22% with clinical MS, due to history of symptoms suggestive of a clinical event, acute or progressive. With an extensive questionnaire, neurologists can detect previous neurological event that patients failed to report. This contrasts with another study where 11% of 104 patients had suspected MS based on MRI [17] . Recently, the PEDIAS study revealed that 44% of patients with a typical CIS had a neurological history suggestive of a previous demyelinating event [18] .
Other published studies showed that in the vast majority of patients who were referred with MRI and other test results may be normal or nonspecifically abnormal. In these cases, definite diagnosis is not possible and follow-up is required. In our cohort, the majority of T2 lesions diagnosed on MRI as possible MS were nonspecific lesions. The medical history and clinical analyses in MS diagnosis are very important [19] . In most patients in whom ultimately another diagnosis was made, it was found that at initial clinical presentation a diagnosis of MS could be rejected based on the association of medical history and MRI findings. Specific symptoms or signs pointing to the disease were not recognized.
With the extending accessibility of MRI, RIS is frequently overdiagnosed, either because medical history examination reveals a suggestive clinical event or the structured MRI analysis rejects the diagnosis of an inflammatory disease. Among our 220 patients, only 18 were finally diagnosed as RIS, others having either neurological symptoms history or T2 lesions nonsuggestive of MS.
Even if incidental brain T2 lesions are frequent, asymptomatic patients with hypersignals and/or gadolinium enhancement fulfilling Barkhof/Tintoré MRI criteria and DT and DS are more rare [12, [20] [21] [22] [23] [24] . DT criteria were present for 82.7% of MS patients and 36% of RIS patients but none of the vascular or nonpathological T2 abnormalities.
In these published cohorts, 80% of patients with a RIS already fulfilled diagnostic criteria before the seminal event. In European or North American observational studies, the authors have found that up to 30-45% of patients with RIS will present clinical progression. [12, 21] The median time to clinical conversion differs between studies being 2. 
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